Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-Small Cell Lung Cancer

A Single-Arm, Open-Label, Interventional Study to Evaluate the Efficacy of HS-IT101 Autologous Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy After Lymphodepleting Preconditioning with Fludarabine and Cyclophosphamide and Subsequent Interleukin-2 Therapy in Patients with Advanced Non-Small Cell Lung Cancer.

Participants needed: 24
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Hangzhou Huasai Biomedicine Co., Ltd.Updated: Sep 29, 2026Locations: 1
Eligibility criteria

Age 18 to 75 years; [+9]

Patients with a history of severe hypersensitivity reactions to any drug used du... [+16]

Status: Recruiting

Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer

A Single-Arm, Open-Label, Interventional Study to Evaluate the Efficacy of HS-IT101 Autologous Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy After Lymphodepleting Preconditioning with Fludarabine and Cyclophosphamide and Subsequent Interleukin-2 Therapy in Patients with Advanced Renal Cancer.

Participants needed: 15
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Hangzhou Huasai Biomedicine Co., Ltd.Updated: Sep 29, 2026Locations: 2
Eligibility criteria

Aged 18 to 75 years old, regardless of gender; [+3]

Use of any immunosuppressive medications, such as corticosteroids, within 4 week... [+11]